Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
1994-8-11
|
pubmed:abstractText |
The bcl-2 gene is a unique proto-oncogene that blocks apoptosis; its product is localized on the inner mitochondrial membrane. In non neoplastic human lymphoid tissues, bcl-2 protein is strongly expressed in the small recirculating lymphocytes of the follicular mantle zone; it is expressed less intensely in T-cell areas, and is almost absent from germinal center cells. Bcl-2 mRNA, in contrast to bcl-2 protein, is strongly expressed on most of the latter cells, a similar phenomenon also being observed in peripheral blood lymphocytes (PBL). Resting PBL express both bcl-2 mRNA and protein, while most lymphoblasts in mitogen-stimulated PBL cultures lose bcl-2 protein and become apoptotic, despite expressing higher levels of mRNA. Posttranscriptional regulation of the bcl-2 gene may cause this paradoxical down-regulation of bcl-2 protein and may play an important role in the clonal selection of lymphocytes. Bcl-2 protein is frequently expressed in follicular lymphomas bearing the t(14;18) chromosomal translocation, but it is also widely expressed in many other B- and T-cell lymphomas without bcl-2 rearrangement, showing that mechanisms other than t(14;18) translocation may deregulate bcl-2 expression. Many lymphoid and myeloid cell lines also express bcl-2 protein with no correlation being shown with differentiation stage. Thus, it is conceivable that bcl-2 protein may play a role in the oncogenesis of many hematolymphoid malignancies by interfering with programmed cell death, in concert with other oncogenes or tumor suppressor genes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1042-8194
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:geneSymbol |
bcl-2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
81-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8025526-Cell Line,
pubmed-meshheading:8025526-Chromosomes, Human, Pair 14,
pubmed-meshheading:8025526-Chromosomes, Human, Pair 18,
pubmed-meshheading:8025526-GTP-Binding Proteins,
pubmed-meshheading:8025526-Gene Expression,
pubmed-meshheading:8025526-Humans,
pubmed-meshheading:8025526-Leukemia,
pubmed-meshheading:8025526-Lymphocytes,
pubmed-meshheading:8025526-Lymphoid Tissue,
pubmed-meshheading:8025526-Lymphoma,
pubmed-meshheading:8025526-Lymphoma, B-Cell,
pubmed-meshheading:8025526-Lymphoma, T-Cell,
pubmed-meshheading:8025526-Proto-Oncogene Proteins,
pubmed-meshheading:8025526-Proto-Oncogene Proteins c-bcl-2,
pubmed-meshheading:8025526-RNA, Messenger,
pubmed-meshheading:8025526-Reference Values,
pubmed-meshheading:8025526-Translocation, Genetic
|
pubmed:year |
1994
|
pubmed:articleTitle |
Expression of Bcl-2 protein and Bcl-2 mRNA in normal and neoplastic lymphoid tissues.
|
pubmed:affiliation |
Department of Pathology, Okayama University Medical School, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|